Ethylacetamide → N-ethyl-N-({4-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]phenyl}methyl)acetamide
반응식
Cl[CH2:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[C:17]3[CH2:16][CH2:15][CH2:14][CH2:13][C:12]=3[C:11]([C:18]([F:21])([F:20])[F:19])=[N:10]2)=[CH:5][CH:4]=1.[CH2:22]([NH:24][C:25](=[O:27])[CH3:26])[CH3:23]>>[CH2:22]([N:24]([CH2:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[C:17]3[CH2:16][CH2:15][CH2:14][CH2:13][C:12]=3[C:11]([C:18]([F:21])([F:20])[F:19])=[N:10]2)=[CH:5][CH:4]=1)[C:25](=[O:27])[CH3:26])[CH3:23]참가 물질
3
실험 절차
The title compound was prepared from 1-[4-(chloromethyl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole and N-ethylacetamide using a similar procedure to that described for Description 15.
출처 및 근거
- ORD 기록
- ord-beea5133b39b477db265294859196c83
- 출처 데이터셋
- uspto-grants-2009_07
- 특허 번호
- US07566735B2
반응 노트
불러오는 중…